Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020



Medical Devices sector report, Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patients sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

1


2 Introduction
2.1 Colorectal Cancer Overview
3 Products under Development
3.1 Colorectal Cancer - Pipeline Products by Stage of Development
3.2 Colorectal Cancer - Pipeline Products by Territory
3.3 Colorectal Cancer - Pipeline Products by Regulatory Path
3.4 Colorectal Cancer - Pipeline Products by Estimated Approval Date
3.5 Colorectal Cancer - Ongoing Clinical Trials
4 Colorectal Cancer - Pipeline Products under Development by Companies
4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development
4.2 Colorectal Cancer - Pipeline Products by Stage of Development
5 Colorectal Cancer Companies and Product Overview
6 Colorectal Cancer- Recent Developments 1887 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List Of Tables

Table 1: Colorectal Cancer - Pipeline Products by Stage of Development
Table 2: Colorectal Cancer - Pipeline Products by Territory
Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path
Table 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date
Table 5: Colorectal Cancer - Ongoing Clinical Trials
Table 6: Colorectal Cancer Companies - Pipeline Products by Stage of Development
Table 7: Colorectal Cancer - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Diagnostic Assay - Colorectal Cancer - Product Status
Table 10: Diagnostic Assay - Colorectal Cancer - Product Description
Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status
Table 13: DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description
Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Veracode - Colorectal Cancer - Product Status
Table 16: Veracode - Colorectal Cancer - Product Description
Table 17: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Cchek - Colon Cancer Confirmatory Test - Product Status
Table 19: Cchek - Colon Cancer Confirmatory Test - Product Description
Table 20: Cchek - Colon Cancer Recurrence Test - Product Status
Table 21: Cchek - Colon Cancer Recurrence Test - Product Description
Table 22: Cchek - Colon Cancer Screening Test - Product Status
Table 23: Cchek - Colon Cancer Screening Test - Product Description
Table 24: Cchek - Colon Cancer Treatment Monitoring Test - Product Status
Table 25: Cchek - Colon Cancer Treatment Monitoring Test - Product Description
Table 26: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 27: Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 28: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: SimpliPro Colon-A - Product Status
Table 30: SimpliPro Colon-A - Product Description
Table 31: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Biomarker Test - Colorectal Cancer - Product Status
Table 33: Biomarker Test - Colorectal Cancer - Product Description
Table 34: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Finger Stick Test - Colon Cancer - Product Status
Table 36: Finger Stick Test - Colon Cancer - Product Description
Table 37: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
Table 38: ArtemixRx Prognostic Test - Colon Cancer - Product Status
Table 39: ArtemixRx Prognostic Test - Colon Cancer - Product Description
Table 40: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: TheraLink Assay - Colorectal Cancer - Product Status
Table 42: TheraLink Assay - Colorectal Cancer - Product Description
Table 43: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Diagnostic Test - Colorectal Adenoma - Product Status

List Of Figures

Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development
Figure 2: Colorectal Cancer - Pipeline Products by Territory
Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path
Figure 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available